Discovery of new ATP-competitive inhibitors of human DNA topoisomerase IIα through screening of bacterial topoisomerase inhibitors-Reference-Cited by-同舟云学术

Discovery of new ATP-competitive inhibitors of human DNA topoisomerase IIα through screening of bacterial topoisomerase inhibitors

Published:2020-09 Issue: Volume:102 Page:104049
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Skok Žiga,Durcik Martina,Gramec Skledar Darja,Barančoková Michaela,Peterlin Mašič Lucija,Tomašič Tihomir,Zega Anamarija,Kikelj Danijel,Zidar Nace,Ilaš Janez

Funder

Slovenian Research Agency

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference50 articles.

1. Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy;Bailly;Chem. Rev.,2012

2. DNA topoisomerases: structure, function, and mechanism;Champoux;Annu. Rev. Biochem.,2001

3. The use of divalent metal ions by type II topoisomerases;Deweese;Met. Integr. Biometal Sci.,2010

4. GHKL, an emergent ATPase/kinase superfamily;Dutta;Trends Biochem. Sci.,2000

5. New N -phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors;Zidar;Med. Chem. Commun.,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains;European Journal of Medicinal Chemistry;2024-11

2. New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity;RSC Advances;2024

3. New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus;Journal of Medicinal Chemistry;2023-03-06

4. ATP-competitive inhibitors of human DNA topoisomerase IIα with improved antiproliferative activity based on N-phenylpyrrolamide scaffold;European Journal of Medicinal Chemistry;2023-03

5. A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents;International Journal of Molecular Sciences;2023-01-28